Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07206017

Explorative Study on Addition of High-fiber Dried Chicory Root in Patients With an Intermediate to High-risk Cutaneous Melanoma.

Exploring the effect of supplementation with daily addition of prebiotic dried chicory root (WholeFiberTM) for 6 weeks on fecal SCFA levels, gut microbial composition and immune cell composition in minimal stage II A melanoma patients following surgical treatment.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years;
  • The participant understands the study and can provide written informed consent;
  • The participant received surgical treatment of an intermediate to high-risk cutaneous melanoma (T2a/N1, T2b, T3a, T3b, T4a, T4b, N0 or N+, M0 stadium without evidence of disease);
  • Being able to read and speak Dutch;
  • Willing to come to the UMCG for practical reasons (visiting the study site);
  • Willing to continue their regular lifestyle patterns during the study.

Exclusion criteria

  • Receiving concurrent adjuvant treatment, adjuvant treatment after the study period is allowed.
  • Having a medical history that may impact study outcomes, such as a diagnosis of diabetes mellitus type 2, heart disease, renal disease, autoimmune disease;
  • Any clinically significant or unstable medical disorder involving the gut, including celiac disease, inflammatory bowel disease, short-bowel syndrome or acute/chronic pancreatitis;
  • Having an ileostomy or colostomy, as this greatly impacts bowel function and gut microbial composition;
  • Use of antibiotics in the 3 months prior participation in the study;
  • Use of prednisolone or other immunosuppressive medication;
  • Use of tube feeding or sib-feeding;
  • Being pregnant or lactating;
  • Participation in another interventional study at the same time;
  • Unable or unwilling to comply to study rules.

Treatment and study plan

prebiotic dried chicory root (WholeFiber)

Other

Supplementing with WholeFiber for 6 weeks two times a day (10 g per portion).

Primary outcomes

  1. Effect of a high fiber prebiotic vegetable (WholeFiber) on fecal SCFA levels

    Time frame: 6 weeks

    Effect of a high fiber prebiotic vegetable (WholeFiber) for 6 weeks on fecal SCFA levels in intermediate to high-risk cutaneous melanoma patients, with no concurrent adjuvant treatment. HPLC ion chromatography system (Metrohm AG, Herisau, Switzerland) will be used to determine the levels of SCFA. The concentrations of SCFA; butyrate, propionate, and acetate will be measured with a conductivity detector. SCFA will be measured at baseline, halfway intervention and after 6 weeks.

Secondary outcomes

  1. Discovering the gut microbial composition changes

    Time frame: 6 weeks

    Discovering the gut microbial composition changes measured in intermediate to high-risk cutaneous melanoma patients with no concurrent adjuvant treatment, after using WholeFiber for 6 weeks. This analysis will be based on whole genome sequencing of fecal samples performed at the UMCG according to standardized protocol.

  2. Exploring the effect of WholeFiber use

    Time frame: 6 weeks

    Exploring the effect of WholeFiber use for 6 weeks on immune functioning, stool patterns, fecal calprotectin levels and side effects in this patient group. Peripheral blood mononuclear cells (PBMCs) and bloodplasma will be isolated to determine immune cell composition before and after the intervention period. Fecal calprotectin will be determined using the respective ELISA kit (Thermo Fisher Scientific). Calprotectin is released when neutrophils enter the gut wall and are activated during the inflammatory process. Lastly, eating patterns, fiber intake before the interventional period, stool patterns and side effects will be identified using the Food Frequency Questionnaire, Bristol Stool Scale, Gastrointestinal Symptoms Rating Scale and Health Related Quality of Life questionnaires.

Study contacts

Contact information is provided by the study sponsor or research team.

Emily Oosterhout, MSc

CONTACT

[email protected]

+31652764949

G. A.P. Hospers, MD, PhD

CONTACT

[email protected]

+31 50 361 2821

Sponsors and collaborators

Lead sponsor

University Medical Center Groningen

Other

Registry information

Official study title

Measuring Effects of High-fiber Dried Chicory Root on the Gut Microbiota of Patients With an Intermediate to High-risk Cutaneous Melanoma: an Explorative Study

Acronym: MELFIB

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Oct 3, 2025
Registry last updated
Oct 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.